Author(s): Lemire JM, Adams JS, Sakai R, Jordan SC
Activated B and T lymphocytes from normal human subjects are known to have the specific high-affinity receptor for 1,25-dihydroxyvitamin D3 (1,25-(OH)2-D3). In an attempt to determine a functional role for the sterol in such cells, we studied the effect of 1,25-(OH)2-D3 on DNA synthesis and Ig production by normal human peripheral blood mononuclear (PBM) cells activated in vitro by the polyclonal lymphocyte activators pokeweed mitogen and phytohemagglutinin, and the specific antigen dermatophyton O. A dose-dependent inhibition of [3H]thymidine incorporation was observed in cells incubated with 1,25-(OH)2-D3 in concentrations ranging from 10(-10) to 10(-7) M. Production of IgG and IgM, determined by enzyme-linked immunosorbent assay, was similarly inhibited by increasing concentrations of 1,25-(OH)2-D3. Half-maximal inhibition of DNA and Ig synthesis was found at 10(-10) to 10(-9) M 1,25-(OH)2-D3. This suppressive effect was specific for 1,25-(OH)2-D3; of the other vitamin D metabolites examined, only 10(-7) M 24R,25 dihydroxyvitamin D3 (24,25-(OH)2-D3) had a similar inhibitory effect. 1,25-(OH)2-D3 was not cytotoxic and did not affect unactivated PBMs. These data demonstrate that 1,25-(OH)2-D3 is a potent inhibitor of human PBM Ig production in vitro and suggest that this action is mediated through the hormone's antiproliferative effect on Ig-producing B cells and/or helper T cells.
Referred From: http://www.jci.org/articles/view/111465
Author(s): Mora JR, Iwata M, von Andrian UH
Author(s): Dusso A, Brown A, Slatopolsky E
Author(s): Merlino LA, Curtis J, Mikuls TR, Cerhan JR, Criswell LA, et al.
Author(s): Devaraj S, Yun JM, Duncan-Staley CR, Jialal I
Author(s): Orgaz-Molina J, Buendía-Eisman A, Arrabal-Polo MA, Ruiz JC
Author(s): Gisondi P, Rossini M, Di Cesare A, Idolazzi L, Farina S, et al.
Author(s): Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, et al.
Author(s): Wilson PB
Author(s): Clemens TL, Garrett KP, Zhou XY, Pike JW, Haussler MR, et al.
Author(s): Adorini L, Penna J
Author(s): Plajo CF, Lopez-Benitez JM, Miller LC
Author(s): Mostafa WZ, Hegazy RA
Author(s): Lesiak A, Narbutt J, Pawlaczyk M, Sysa-Jedrzejowska A, Krzyścin J
Author(s): Cicarma E, Mork C, Porojnicu AC, Juzeniene A, Tam TT, et al.
Author(s): Ryan C, Moran B, McKenna MJ, Murray BF, Brady J, et al.
Author(s): Ala-houhala MJ, Karppinen TT, Vahavihu K, Kautiainen H, Dombrowski Y, et al.
Author(s): Osmancevic A, Landin-Wilhelmsen K, Larko O, Krogstad AL
Author(s): Zuchi MF, Azevedo Pde O, Tanaka AA, Schmitt JV, Martins LE
Author(s): Maleki M, Nahidi Y, Azizahari S, Meibodi NT, Hadianfar A
Author(s): Park BS, Park JS, Lee DY, Youn JI, Kim IG
Author(s): Valdivielso JM, Fernandez E